Australia markets closed

Anagenics Limited (AN1.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0100+0.0010 (+11.11%)
At close: 12:30PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
9,113
9,113
9,235
5,816
7,381
Cost of revenue
4,702
4,702
4,170
2,113
2,534
Gross profit
4,412
4,412
5,065
3,704
4,847
Operating expenses
Research development
21.193
21.193
110.347
118.793
849.019
Selling general and administrative
5,876
5,876
8,229
5,893
7,199
Total operating expenses
6,747
6,747
9,627
8,228
11,279
Operating income or loss
-2,336
-2,336
-4,562
-4,524
-6,432
Interest expense
31.844
31.844
69.86
54.756
71.257
Total other income/expenses net
611.479
611.479
464.809
343.242
1,147
Income before tax
-1,734
-1,734
-3,644
-3,760
-4,818
Income tax expense
7.87
7.87
4.783
45.049
89.473
Income from continuing operations
-1,742
-1,742
-3,649
-3,805
-4,907
Net income
-2,667
-2,667
-3,649
-3,387
-4,907
Net income available to common shareholders
-2,667
-2,667
-3,649
-3,387
-4,907
Basic EPS
-0.01
-0.01
-0.02
-0.02
-0.05
Diluted EPS
-0.01
-0.01
-0.02
-0.02
-0.05
Basic average shares
265,950
265,950
211,374
142,533
105,584
Diluted average shares
265,950
265,950
211,374
142,533
105,584